Sorry!! The article you are trying to read is not available now.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
XOMA (NQ: XOMA)
0.4986 USD  +0.0026 (+0.52%)
Streaming Delayed Price  /  Updated: 9:33 AM EDT, Sep 27, 2016  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 12,125
Open 0.4900
Bid (Size) 0.4800 (42900)
Ask (Size) 0.5000 (1000)
Prev. Close 0.4960
Today's Range 0.4800 - 0.4986
52wk Range 0.4400 - 2.030
Shares Outstanding 120,591,288
Dividend Yield N/A
Performance
YTD
-62.79%
-62.79%
1 Month
-14.42%
-14.42%
3 Month
+10.68%
+10.68%
6 Month
-31.34%
-31.34%
1 Year
-35.26%
-35.26%
Top News
More News
XOMA Provides Update from Ongoing Phase 2 XOMA 358 Clinical Studies
XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, provided an update on its ongoing XOMA 358 Phase 2 studies in patients with severe hypoglycemia due... Read More
from GlobeNewswire News Releases
XOMA to Host XOMA 358 Clinical Update Webcast and Conference Call on September 15, 2016
XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today it will host a webcast and conference call on September 15, 2016, at 1:30 p.m. PDT... Read More
from GlobeNewswire News Releases
More News
Read More
Biotech Stocks on Investors' Radar -- Illumina, XOMA, Lexicon Pharma, and VIVUS
from PR Newswire
XOMA to Present at the 2016 Wedbush PacGrow Healthcare Conference
from GlobeNewswire News Releases
XOMA Reports Second Quarter 2016 Achievements and Financial Results
from GlobeNewswire News Releases
XOMA Receives Orphan Drug Designation in the European Union for XOMA 358 for Treatment of Congenital Hyperinsulinism
from GlobeNewswire News Releases
XOMA to Present at the Cantor Fitzgerald Healthcare Conference
from GlobeNewswire News Releases
Why Investors Love These Biotech's Stocks? - XOMA Corp., Navidea Biopharma, Radius Health, and Cara Therapeutics
from PR Newswire
XOMA Initiates Phase 2 Proof-of-Concept Study of XOMA 213
from GlobeNewswire News Releases
XOMA to Present at the Jefferies Global Healthcare Conference
from GlobeNewswire News Releases
XOMA Reports First Quarter 2016 Operational Achievements and Financial Results
from GlobeNewswire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
Last week's market recap:
2
Another Try
3
SP 500 Weekly Earnings Update: Bullish for Next 2 Quarters, Election Notwithstanding
4
Star Health Insurance Renewal Online
5
Coverage Under LIC Medical Insurance